Zhanhai Mai

Dr. Zhanhai Mai


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2024 in Animals
Verified
Journal Article
Open access
PDF file
XZxijun zhang
xijun zhang
YGYujin Gao
Yujin Gao
ZMZhanhai Mai
Zhanhai Mai
YLYina Li
Yina Li
JWjiamian wang
jiamian wang
YZYong Zhang
Yong Zhang
The aim of this study was to explore alterations in plasma metabolites among mares afflicted with endometritis. Mares were divided into two groups, namely, the equine endometritis group (n = 8) and the healthy control group (n = 8), which included four pregnant and four non-pregnant mares, using a combination of clinical assessment and laboratory confirmation. Plasma samples from both groups of mares were analyzed through untargeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) metabolomics. A total of 28 differentially abundant metabolites were identified by screening and identifying differentially abundant metabolites and analyzing the pathway enrichment of differentially. Ten metabolites were identified as potential biomarkers for the diagnosis of endometritis in mares. Among them, seven exhibited a decrease in the endometritis groups, including hexadecanedioic acid, oleoyl ethanolamide (OEA), [fahydroxy(18:0)]12_13-dihydroxy-9z-octa (12,13-diHOME), deoxycholic acid 3-glucuronide (DCA-3G), 2-oxindole, and (+/-)9-HPODE, and 13(S)-HOTRE. On the other hand, three metabolites, adenosine 5′-monophosphate (AMP), 5-hydroxy-dl-tryptophan (5-HTP), and l-formylkynurenine, demonstrated an increase. These substances primarily participate in the metabolism of tryptophan and linolenic acid, as well as fat and energy. In conclusion, metabolomics revealed differentially abundant metabolite changes in patients with mare endometritis. These specific metabolites can be used as potential biomarkers for the non-invasive diagnosis of mare endometritis.

27 October 2025 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
HFHan Fu
Han Fu
TLTongyang Li
Tongyang Li
YWYuyan Wang
Yuyan Wang
YYYang Yang
Yang Yang
YLYabin Lu
Yabin Lu
QGQing-Yong Guo
Qing-Yong Guo
Introduction: Equine abortus salmonellosis, caused by Salmonella abortus equi ( S. abortus equi ), is a contagious disease primarily characterized by abortion in pregnant equine animals. Due to its high pathogenicity and increasing incidence, this disease has attracted significant scientific attention. While the causes of abortion in mares are multifactorial and may involve numerous pathogenic factors, the specific impact of S. abortus equi on the vaginal microecological environment and its pivotal role as the primary causative agent of abortion remain poorly understood. Results: Further analysis led to the successful isolation and identification of S. abortus equi from vaginal samples of aborted mares. A highly pathogenic isolate, designated as XJ2032, was selected for further analysis. To gain a more profound understanding of the functional genomic composition and genetic traits of this strain, whole-genome sequencing was conducted, and sophisticated bioinformatics techniques were employed to predict and annotate its gene sequences. Furthermore, animal model experiments, and PCR-based molecular biological detection methods were utilized to assess the virulence and drug resistance genes of the isolated strain XJ2032, further confirming its pathogenic potential. Conclusion: Whole-genome sequencing analysis confirmed that strain XJ2032 is indeed S. abortus equi . Although its genome structure is largely conserved, some rearrangements and inversions were identified. The strain harbors multiple virulence genes and drug resistance genes, including horizontally transferable genes and mobile genetic elements. These findings suggest that genomic islands and bacteriophages play a vital role in the pathogenicity and genetic diversity of S. abortus equi .

8 April 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YLYabin Lu
Yabin Lu
SMSajidaimu Maimaiti
Sajidaimu Maimaiti
ZQZhanke Qin
Zhanke Qin
XCXinke Cheng
Xinke Cheng
JLJianlong Li
Jianlong Li
ZMZhanhai Mai
Zhanhai Mai
Introduction: Ficus carica L. polysaccharides (FLPs) are groups of biologically active compounds extracted from Ficus carica L.Methods: In this study, we analyzed the structure of FLPs, predicted their immune enhancement pathway, and detected the impact of FLPs on the growth performance, immune function, and intestinal microflora of broiler chickens.Results: The results showed that FLPs are comprised of monosaccharides including rhamnose, arabinose, mannose, glucose, and galactose. Feeding with FLPs significantly promoted the growth performance, slaughtering performance, and immune organs index of chickens compared to the control group (p < 0.05). Moreover, the FLP-h and FLP-m groups had increased levels of sIgA, IgG, IL-4, IL-5, IL-12, and IFN-g; improved immunity and barrier function; and a higher percentage of spleen CD4+ and CD8+ T cell differentiation compared to the control group (p < 0.05). Additionally, the FLP-h group had increased levels of various SCFAs, and increased beneficial bacteria such as Firmicutes at the phylum level and Faecalibacterium, Blautia, Phascolarctobacterium, and Alistipes at the genus level. The results of network pharmacology and KEGG pathway prediction indicate that FLPs may change the structure and metabolism of intestinal microbiota by enhancing carbon fixation pathways in prokaryotes, and promote intestinal immune barrier function through the joint action of bisphenol degradation, retinol metabolism, NODlike signaling pathways, toll-like receptor signaling pathways, and the MAPK signaling pathway. Discussion: These results suggest that FLP-h supplementation effectively promotes growth performance and enhances the intestinal mucosal immune barrier function in chickens.

Verified
Journal Article
Open access
PDF file
ZSZhiran Shao
Zhiran Shao
SMSiqi Ma
Siqi Ma
FGFengSiyue Gao
FengSiyue Gao
YLYang Lou
Yang Lou
XLXinyi Liu
Xinyi Liu
QFQiang Fu
Qiang Fu
Bovine Viral Diarrhea Virus (BVDV) poses a significant threat to the global cattle industry, causing substantial economic losses. Long non-coding RNAs (lncRNAs) play crucial regulatory roles in various biological processes, including viral infections. However, the specific lncRNAs influencing BVDV replication remain poorly characterized. This study identified lncSMIM14 as a key host factor upregulated during BVDV infection in MDBK cells. Functional analyses demonstrated that lncSMIM14 overexpression significantly enhanced BVDV replication, evidenced by increased viral mRNA levels, progeny virus titers, cytopathic effects, and dsRNA abundance, while its knockdown exerted the opposite effect. Mechanistically, we revealed that lncSMIM14 specifically targets and positively regulates the expression of the endocytosis-related GTPase Rab3a. Importantly, Rab3a itself was shown to be essential for efficient BVDV replication, as its overexpression promoted viral replication, and its knockdown inhibited it. Furthermore, Rab3a co-localized with key endocytic regulators Rab5a and Rab7a, and both lncSMIM14 overexpression and Rab3a overexpression promoted the formation of endocytic vesicles, particularly post-BVDV infection. Our findings unveil a novel mechanism wherein BVDV exploits the host lncRNA lncSMIM14 to hijack Rab3a-mediated endocytosis, facilitating its own replication. This study identifies the lncSMIM14-Rab3a axis as a critical host pathway subverted by BVDV, providing new potential targets for antiviral intervention.

2 January 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
致Z致远 Zhang
致远 Zhang
YYYangYang Yang
YangYang Yang
QGQingyong Guo
Qingyong Guo
ZMZhanhai Mai
Zhanhai Mai
HFHan Fu
Han Fu
QGQingyong Guo
Qingyong Guo
With the growing popularity of equestrian sports, the incidence of athletic injuries in horses has also risen. Among these injuries, proximal sesamoid bone fracture (PSBF) and flexor tendinitis are particularly common in the forelimbs of sport horses and represent major causes of musculoskeletal impairment. A 5-year-old horse presented with obvious symptoms such as swelling at the left fetlock joint and metacarpal region after exercise. Through lameness assessment, diagnostic imaging, and hematological testing, the horse was diagnosed with PSBF complicated by flexor tendinitis. The affected horse was treated with non-steroidal anti-inflammatory drugs combined with low-intensity pulsed ultrasound (LIPUS) therapy. After treatment, local microcirculation at the fracture and flexor tendon sites was improved, tissue healing was accelerated, and clinical indicators were stabilized. This case report demonstrates the potential of LIPUS-assisted therapy in promoting the recovery of horses with PSBF and concurrent flexor tendinitis, providing a valuable clinical reference for the management of complex musculoskeletal injuries in veterinary practice.

14 August 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
DWDong Wang
Dong Wang
ZNZheng Nie
Zheng Nie
WZWenzheng Zhang
Wenzheng Zhang
JLJinhui Liu
Jinhui Liu
CGChangqi Ge
Changqi Ge
QGQingyong Guo
Qingyong Guo
Nontoxigenic Bacteroides fragilis (NTBF) is defined by the absence of the bft gene and corresponding B. fragilis toxin production; however, nontoxigenic status alone does not establish uniform safety or probiotic function. This review critically evaluates strain-level biological characteristics, safety, mechanisms, metabolites, and disease-model evidence. Selected strains and defined strain-derived preparations, including ZY-312, HCK-B3, NCTC 9343-derived polysaccharide A, and ZY-312-derived zwitterionic capsular polysaccharide preparation TP2, have shown immunomodulatory, barrier-associated, and microbial-community-modulating activities, predominantly in vitro and in animal models. Direct causal evidence is limited to specific strain–preparation–host–model combinations, whereas many changes in cytokines, tight-junction-associated proteins, microbial composition, and organic-acid profiles remain functional or associative. Protective effects have been reported in preclinical models of inflammatory bowel disease, necrotizing enterocolitis, antibiotic-associated diarrhea, Clostridioides difficile infection, and enterotoxigenic B. fragilis (ETBF)-associated tumorigenesis. However, findings are highly dependent on the strain, preparation, dose, administration timing, host, and model. Safety remains incompletely resolved because the absence of B. fragilis toxin (BFT) does not exclude opportunistic or systemic infection, antimicrobial-resistance mobility, bacterial translocation, permeability changes, or adverse effects during long-term administration. Metabolic effects may also be beneficial or adverse depending on the strain, host dietary and genetic background, and experimental context. Human evidence is primarily observational, and robust intervention trials are lacking. Accordingly, NTBF should be regarded as a heterogeneous group of strain-specific live-biotherapeutic candidates requiring rigorous strain-specific manufacturing, potency, dose, antimicrobial-susceptibility, and safety evaluation.